Guided Therapeutics Inc (GTHP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Guided Therapeutics Inc (GTHP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011717
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva advanced cervical scan and esophageal dysplasia detection system. GTI develops technology to painlessly detect disease before it becomes cancer. The company’s LuViva advanced cervical scan product is a non-invasive device used to detect cervical disease instantly at the point of care. Its esophageal dysplasia detection system is a non-invasive point of care device which uses biophotonics to scan the surface of the esophagus. GTI is headquartered in Norcross, Georgia, the US.

Guided Therapeutics Inc (GTHP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guided Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Guided Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Guided Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Guided Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Guided Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Guided Therapeutics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Shandong Yaohua Medical Enters into Licensing Agreement with Guided Therapeutics 10
Guided Therapeutics Enters into Licensing Agreement for LuViva 11
Guided Therapeutics Enters Into Licensing Agreement With Konica Minolta 12
Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta 13
ITEM Medical Enters into Licensing Agreement with Guided Therapeutics 14
GUIDED THERAPEUTICS Extends Co-Development Agreement With Konica Minolta 15
Shenghuo Medical Enters into Licensing Agreement with Guided Therapeutics for LuViva 16
Equity Offering 17
Guided Therapeutics Raises USD1.3 Million in First Tranche of Private Placement of Shares 17
Guided Therapeutics Raises USD0.7 Million in Private Placement of Shares 18
Guided Therapeutics Raises USD0.2 Million in Private Placement of Shares 19
Guided Therapeutics Completes Private Placement Of Shares And Warrants For US$2.5 Million 20
Guided Therapeutics Completes Private Placement Of Shares For US$1.6 Million Upon Exercise Of Warrants 21
Debt Offering 22
Guided Therapeutics Raises USD0.16 Million in Private Placement of 12% Convertible Note 22
Guided Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes 23
Guided Therapeutics Inc – Key Competitors 24
Guided Therapeutics Inc – Key Employees 25
Guided Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 17, 2016: Guided Therapeutics Reports Second Quarter 2016 Financial Results; Year to Date Revenue Up 71% Over Same Period Last Year 27
May 19, 2016: Guided Therapeutics Reports Record First Quarter 2016 Results 29
Product News 30
03/16/2016: Guided Therapeutics Shipping Largest Order to Date of LuViva Advanced Cervical Scan Single-Patient-Use Disposables 30
03/09/2016: Guided Therapeutics’ LuViva Advanced Cervical Scan Gaining Traction in the Middle East 31
03/03/2016: Guided Therapeutics Targeting Large Cervical Cancer Screening Markets with LuViva Advanced Cervical Scan with New Single-Patient-Use Disposable 32
02/09/2016: Guided Therapeutics Expands LuViva Advanced Cervical Scan Distribution in Latin America 33
01/28/2016: Guided Therapeutics’ to Sell Five Additional LuViva Advanced Cervical Scans to Nairobi County, Kenya for Cervical Cancer Screening Program 34
01/21/2016: Guided Therapeutics Expects Significant Sales Growth in 2016 35
01/12/2016: Guided Therapeutics Achieves Record Quarterly Revenue 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Guided Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Guided Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Guided Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Guided Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Guided Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Guided Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Guided Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Shandong Yaohua Medical Enters into Licensing Agreement with Guided Therapeutics 10
Guided Therapeutics Enters into Licensing Agreement for LuViva 11
Guided Therapeutics Enters Into Licensing Agreement With Konica Minolta 12
Guided Therapeutics Extends Licensing And Co-Development Agreement With Konica Minolta 13
ITEM Medical Enters into Licensing Agreement with Guided Therapeutics 14
GUIDED THERAPEUTICS Extends Co-Development Agreement With Konica Minolta 15
Shenghuo Medical Enters into Licensing Agreement with Guided Therapeutics for LuViva 16
Guided Therapeutics Raises USD1.3 Million in First Tranche of Private Placement of Shares 17
Guided Therapeutics Raises USD0.7 Million in Private Placement of Shares 18
Guided Therapeutics Raises USD0.2 Million in Private Placement of Shares 19
Guided Therapeutics Completes Private Placement Of Shares And Warrants For US$2.5 Million 20
Guided Therapeutics Completes Private Placement Of Shares For US$1.6 Million Upon Exercise Of Warrants 21
Guided Therapeutics Raises USD0.16 Million in Private Placement of 12% Convertible Note 22
Guided Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes 23
Guided Therapeutics Inc, Key Competitors 24
Guided Therapeutics Inc, Key Employees 25

★海外企業調査レポート[Guided Therapeutics Inc (GTHP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Continental Resources, Inc. (CLR):企業概要、財務及び戦略的SWOT分析
    Summary Continental Resources, Inc. (Continental Resources) is an oil and gas company. The company explores and produces crude oil and natural gas products. Its operations include Bakken/Three Forks, Red River Units, Niobrara, Anadarko Woodford and Arkoma Woodford. Continental Resources’ operations …
  • Penske Automotive Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Penske Automotive Group, Inc. M …
  • Noble Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers drug, vaccine, and medical device development services. The company provides preclinical services such as analytical and laboratory services, disease and animal models, drug pharmacology and explora …
  • The Ambassador Hotel, Ltd.:企業の戦略・SWOT・財務分析
    SummaryThe Ambassador Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Avensia AB (AVEN):企業の財務及び戦略的SWOT分析
    Summary Avensia AB (Avensia) formerly InXL innovation AB is an information technology solutions company that offers system development services. The company provides information technology systems for e-commerce and systems development in Sweden. It offers e-learning solutions including education, a …
  • BioLargo, Inc. (BLGO):企業概要、財務及び戦略的SWOT分析
    Summary BioLargo, Inc. (BioLargo) is a chemical company. The company harnesses and delivers nature's disinfectant iodine. Its technologies include CupriDyne, BioLargo AOS Filter, and Isan system. BioLargo delivers controlled dosages of its chemistry in liquid, solid and gas phase reactions. The comp …
  • Yale University:企業のM&A・提携動向(医療分野)
    Summary Yale University (Yale) is a research and educational institution that provides educational programs and educational courses. The institution provides graduate, undergraduate, professional and distance learning programs, and summer courses. Its academic programs include African American studi …
  • Mytilineos Holdings S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mytilineos Holdings S.A. Merger …
  • Small Bone Innovations, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Small Bone Innovations, Inc. (SBI) is medical equipment company. The company develops and distributes orthopedic implants for healthcare markets. Its product portfolio includes star ankle,a3 fusion nail,ringfix,ringfix rad,autofix stainless steel,percufix,twistofix, stafix,mini rail, system …
  • Sohar Power Company SAOG:発電所・企業SWOT分析
    Sohar Power Company SAOG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Silence Therapeutics Plc (SLN):企業の財務及び戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a biotechnology company that develops and delivers RNA interference (RNAi) therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is used to treat for …
  • COFIDIS:企業の戦略・SWOT・財務分析
    SummaryCOFIDIS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - Deta …
  • OptiScan Biomedical Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OptiScan Biomedical Corporation …
  • Digital Arts Inc. (2326):企業財務及び戦略的SWOT分析
    Summary Digital Arts Inc. (Digital Arts) is a technology company that develops, sells and markets internet security software and appliances. The company offers products, which include i-Filter for business, m-Filter, D-SPA, i-Filter browser and cloud, finalcode, ARS and i-Filter. It provides service …
  • Qatar Electricity & Water Company QSC (QEWS)-エネルギー分野:企業M&A・提携分析
    Summary Qatar Electricity & Water Company QSC (QEWC) is an energy utility. The company generates electricity and desalinates water. It owns and operates various power generation and water desalination stations: QEWC also has interests in all power and water companies in the country. The State of Qat …
  • Thai Solar Energy Co., Ltd.:企業のM&A・提携動向(発電分野)
    Summary Thai Solar Energy Co., Ltd. (TSE), formerly Thai Solar Energy Public Company Limited, TSE is a renewable energy company that develops electricity from solar thermal power using parabolic trough technology, for commercial and social societies. The company’s projects specialize in the areas of …
  • Vanguard Natural Resources, LLC:企業のM&A・提携・投資分析
    Vanguard Natural Resources, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vanguard Natural Resources, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Calamos Asset Management, Inc. (CLMS):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Calamos Asset Management, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric str …
  • BearingPoint, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BearingPoint, Inc. Mergers and …
  • Himachal Futuristic Communications Limited (HFCL):企業概要、財務及び戦略的SWOT分析
    Summary Himachal Futuristic Communications Limited (HFCL) is a telecommunication product manufacturing company. The company manufactures and markets telecom products and provides turnkey solutions. It offers products and systems such as perimetric fencing systems, parking management systems, CCTV su …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆